APA (7th ed.) Citation

H, N., R, N. M., M, E., A, R., K, H., S, K., & M, Y. (2021). Topical ketorolac as an adjunctive treatment with intravitreal bevacizumab in the management of diabetic macular edema: A double-masked placebo-controlled randomized clinical trial. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 259(10), 2949. https://doi.org/10.1007/s00417-021-05169-1

Chicago Style (17th ed.) Citation

H, Nikkhah, Niazpour Moez R, Entezari M, Ramezani A, Hassanpour K, Karimi S, and Yaseri M. "Topical Ketorolac as an Adjunctive Treatment with Intravitreal Bevacizumab in the Management of Diabetic Macular Edema: A Double-masked Placebo-controlled Randomized Clinical Trial." Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie 259, no. 10 (2021): 2949. https://doi.org/10.1007/s00417-021-05169-1.

MLA (9th ed.) Citation

H, Nikkhah, et al. "Topical Ketorolac as an Adjunctive Treatment with Intravitreal Bevacizumab in the Management of Diabetic Macular Edema: A Double-masked Placebo-controlled Randomized Clinical Trial." Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, vol. 259, no. 10, 2021, p. 2949, https://doi.org/10.1007/s00417-021-05169-1.